Study examines whether gestational hypertension, preeclampsia and eclampsia are associated with new-onset neurological disorders months to years after giving birth.
A Health Canada safety review concludes that there is a possible link between statin (HMG-CoA reductase inhibitor) use and the risk of myasthenia gravis.
